Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HYDRA LTE
NCT02434497Phase 3Completed
- Sponsor
- AstraZeneca
- Start
- Jun 2015
- Primary completion
- Nov 2016
- Modality
- Orthosteric Ligands
- Countries
- 6
01
Overview
A Phase 3 trial of rosuvastatin in homozygous familial hypercholesterolemia (HoFH), sponsored by AstraZeneca. Started Jun 2015; status: completed.
02
Drugs
rosuvastatin
03
Conditions
homozygous familial hypercholesterolemia (HoFH)
Beyond the preview
Go deeper on NCT02434497.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02434497.